US EditionMelatonin to Be Sold over Counter at NZ Pharmacies, 'Magic Mushroom' Rules Relaxed
- On June 18, 2025, New Zealand authorized a psychiatrist to prescribe psilocybin for treatment-resistant depression and announced melatonin will be available over the counter in pharmacies.
- These changes follow growing medical interest and the 2023 Australian reclassification allowing psychiatrists to prescribe psilocybin under strict oversight.
- The authorized psychiatrist has prior clinical trial experience and must adhere to strict reporting, while melatonin remains prescription-only for children requiring greater oversight.
- Associate Health Minister David Seymour described the development as a major breakthrough for individuals with depression who have exhausted other treatment options and continue to struggle, and he urged melatonin producers to seek approval to supply the product domestically.
- These decisions aim to improve access to effective depression treatments and make melatonin more accessible, reducing reliance on challenging overseas purchases.
Insights by Ground AI
Does this summary seem wrong?
11 Articles
11 Articles
All
Left
2
Center
3
Right
1
New Zealand Approves ‘Shrooms’ to Treat Depression
Psilocybin—a notorious hallucinogen found in “magic mushrooms”—is a federally controlled substance that the U.S. deems to have “no currently accepted medical use” and “a high potential for abuse.” But not everyone agrees with that assessment: New Zealand on Wednesday became the latest country to approve the use of the substance for therapeutic purposes. [time-brightcove not-tgx=”true”] David Seymour, New Zealand’s Associate Minister for Health, …
·United States
Read Full Article
Coverage Details
Total News Sources11
Leaning Left2Leaning Right1Center3Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 33%
C 50%
R 17%
Factuality
To view factuality data please Upgrade to Premium
